CytoSorbents(CTSO) - 2023 Q4 - Earnings Call Presentation

The Unrecognized Faces of Critical Illness CytoSorbents Corporation Q4 2023 and FY 2023 Earnings Conference Call March 14, 2024 Conference Call Participants Moderator: Taylor Devlin CytoSorbents Corporation Phillip Chan, MD, PhD Chief Executive Officer Vincent Capponi, MS President and Chief Operating Officer Efthymios "Makis" Deliargyris MD, FACC, FESC, FSCAI Chief Medical Officer Kathleen Bloch, MBA, CPA Chief Financial Officer Christian Steiner, MD Executive VP Sales & Marketing Managing Director CytoSor ...